CRISPR Therapeutics AG (CRSP) Exchange Rate Effect (2015 - 2026)
CRISPR Therapeutics AG's (CRSP) quarterly Exchange Rate Effect came in at $6000.0 in Q2 2026, down 92.5% year-over-year from $80000.0 in Q2 2025, and up 118.75% quarter-over-quarter from -$32000.0 in Q1 2026.
Powered by 
Analysis
CRISPR Therapeutics AG (CRSP) Exchange Rate Effect (2015 - 2026) Analysis & Trends
CRISPR Therapeutics AG has disclosed Exchange Rate Effect across 12 years of filings, most recently posting $6000.0 for Q2 2026.
- In Q2 2026, Exchange Rate Effect fell 92.5% year-over-year to $6000.0; the TTM figure through Jun 2026 stood at -$52000.0 (down 147.71% YoY), while the FY2025 annual figure was $95000.0, up 552.38% from the prior year.
- Exchange Rate Effect came in at $6000.0 for Q2 2026 at CRISPR Therapeutics AG, up from -$32000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $115000.0 in Q4 2022 to a low of -$100000.0 in Q3 2022.
- Average Exchange Rate Effect over 5 years is $2277.8, with a median of $1500.0 recorded in 2024.
- Year-over-year, Exchange Rate Effect plunged 1460.0% in 2022 and jumped 3900.0% in 2025.
- Over 5 years, Exchange Rate Effect stood at $115000.0 in 2022, then slumped by 46.96% to $61000.0 in 2023, then tumbled by 242.62% to -$87000.0 in 2024, then surged by 101.15% to $1000.0 in 2025, then jumped by 500.0% to $6000.0 in 2026.
- Per Business Quant data, the three most recent Exchange Rate Effect figures were $6000.0 in Q2 2026, -$32000.0 in Q1 2026, and $1000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | -1.83 Mn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | 6,000.00 |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | -124,000.00 |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | -300,000.00 |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | -774,000.00 |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 1,000.00 |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | - |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | - |
| 10 | Taysha Gene Therapies | 1.97 Bn | 1.97 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6,000.00 |
| Mar 31, 2026 | -32,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Sep 30, 2025 | -27,000.00 |
| Jun 30, 2025 | 80,000.00 |
| Mar 31, 2025 | 41,000.00 |
| Dec 31, 2024 | -87,000.00 |
| Sep 30, 2024 | 75,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Mar 31, 2024 | -11,000.00 |
| Dec 31, 2023 | 61,000.00 |
| Sep 30, 2023 | -48,000.00 |
| Jun 30, 2023 | 28,000.00 |
| Mar 31, 2023 | 32,000.00 |
| Dec 31, 2022 | 115,000.00 |
| Sep 30, 2022 | -100,000.00 |
| Jun 30, 2022 | -68,000.00 |
| Mar 31, 2022 | -27,000.00 |
| Dec 31, 2021 | 3,000.00 |
| Sep 30, 2021 | -24,000.00 |